Literature DB >> 11156814

Treatment utilization by patients with personality disorders.

D S Bender1, R T Dolan, A E Skodol, C A Sanislow, I R Dyck, T H McGlashan, M T Shea, M C Zanarini, J M Oldham, J G Gunderson.   

Abstract

OBJECTIVE: Utilization of mental health treatment was compared in patients with personality disorders and patients with major depressive disorder without personality disorder.
METHOD: Semistructured interviews were used to assess diagnosis and treatment history of 664 patients in four representative personality disorder groups-schizotypal, borderline, avoidant, and obsessive-compulsive-and in a comparison group of patients with major depressive disorder.
RESULTS: Patients with personality disorders had more extensive histories of psychiatric outpatient, inpatient, and psychopharmacologic treatment than patients with major depressive disorder. Compared to the depression group, patients with borderline personality disorder were significantly more likely to have received every type of psychosocial treatment except self-help groups, and patients with obsessive-compulsive personality disorder reported greater utilization of individual psychotherapy. Patients with borderline personality disorder were also more likely to have used antianxiety, antidepressant, and mood stabilizer medications, and those with borderline or schizotypal personality disorder had a greater likelihood of having received antipsychotic medications. Patients with borderline personality disorder had received greater amounts of treatment, except for family/couples therapy and self-help, than the depressed patients and patients with other personality disorders.
CONCLUSIONS: These results underscore the importance of considering personality disorders in diagnosis and treatment of psychiatric patients. Borderline and schizotypal personality disorder are associated with extensive use of mental health resources, and other, less severe personality disorders may not be addressed sufficiently in treatment planning. More work is needed to determine whether patients with personality disorders are receiving adequate and appropriate mental health treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156814     DOI: 10.1176/appi.ajp.158.2.295

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  126 in total

1.  Prevalence of personality disorders using two diagnostic systems in psychiatric outpatients in Shanghai, China: a comparison of uni-axial and multi-axial formulation.

Authors:  Tianhong Zhang; Lanlan Wang; Mary-Jo D Good; Byron J Good; Annabelle Chow; Yunfei Dai; Junhan Yu; Haiyin Zhang; Zeping Xiao
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-12-08       Impact factor: 4.328

2.  Preparing for DSM 5 - assessment of personality pathology during psychoanalytic and psychiatric treatments.

Authors:  Henriette Löffler-Stastka; Matthias Bartenstein; Golda Schlaff
Journal:  Wien Klin Wochenschr       Date:  2011-04-26       Impact factor: 1.704

Review 3.  New developments in the neurobiology of borderline personality disorder.

Authors:  Martin Bohus; Christian Schmahl; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 4.  Update on pharmacotherapy of borderline personality disorder.

Authors:  Mary C Zanarini
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 5.  The latest neuroimaging findings in borderline personality disorder.

Authors:  Jana Mauchnik; Christian Schmahl
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

6.  State effects of major depression on the assessment of personality and personality disorder.

Authors:  Leslie C Morey; M Tracie Shea; John C Markowitz; Robert L Stout; Christopher J Hopwood; John G Gunderson; Carlos M Grilo; Thomas H McGlashan; Shirley Yen; Charles A Sanislow; Andrew E Skodol
Journal:  Am J Psychiatry       Date:  2010-02-16       Impact factor: 18.112

7.  Modeling stability and change in borderline personality disorder symptoms using the revised Interpersonal Adjective Scales-Big Five (IASR-B5).

Authors:  Aidan G C Wright; Aaron L Pincus; Mark F Lenzenweger
Journal:  J Pers Assess       Date:  2010-11

8.  Borderline personality disorder and related constructs as risk factors for intimate partner violence perpetration.

Authors:  Michelle A Jackson; Lauren M Sippel; Natalie Mota; Diana Whalen; Julie A Schumacher
Journal:  Aggress Violent Behav       Date:  2015-05-02

9.  Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population.

Authors:  Daniel T Hackman; Marion S Greene; Taya J Fernandes; Ashley M Brown; Eric R Wright; R Andrew Chambers
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

10.  Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.

Authors:  Carlos M Grilo; Charles A Sanislow; John G Gunderson; Maria E Pagano; Shirley Yen; Mary C Zanarini; M Tracie Shea; Andrew E Skodol; Robert L Stout; Leslie C Morey; Thomas H McGlashan
Journal:  J Consult Clin Psychol       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.